CLINICAL_TRIALS trial_result · 2016-03-08

Clinical Trial Update: Safety and Efficacy of IQP- AK-102 in Reducing Body Weight [Phase 3]

Phase 3 study evaluating IQP-AK-102 for reducing body weight has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: InQpharm Group | Conditions: Weight Loss | Phase 3 | Status: COMPLETED | Results posted: 2016-03-08